Idera Pharmaceuticals, Inc. (IDRA)

Trade IDRA now with
7/15/2020 8:18:45 AM Idera Plans Private Placement Of Up To $20.0 Mln
3/5/2020 7:17:19 AM Idera Completes Enrollment In Registrational Trial Of Tilsotolimod In Combination With Ipilimumab
1/14/2020 7:10:41 AM Idera Provides Corporate Outlook For 2020
10/21/2019 7:11:04 AM Idera Announces New U.S. Patent For Tilsotolimod Through September 2037
9/30/2019 7:40:34 AM Idera Announces Initiation Of Phase 2 Trial, ILLUMINATE-206
9/4/2019 7:10:00 AM Idera Pharma Announces Immuno-Oncology Clinical Research Collaboration With AbbVie
7/23/2019 7:37:08 AM Idera Names Elizabeth Tarka Chief Medical Officer; Promotes John Kirby To CFO
4/10/2019 7:09:07 AM Idera Pharma Provides Corporate Update
2/27/2019 7:13:43 AM Idera Pharma Completes Enrollment Into The ILLUMINATE-204 Trial Of The Combination Of Tilsotolimod And Ipilimumab
12/18/2018 4:08:27 PM Idera Pharmaceuticals Appoints Carol Schafer To Its Board Of Directors
12/14/2018 7:07:16 AM Idera Pharma Presents Clinical Update From ILLUMINATE-204 Trial Of Combination Of Tilsotolimod And Ipilimumab
9/18/2018 4:02:06 PM Idera Pharmaceuticals Appoints Howard Pien To Its Board Of Directors